No connection

Search Results

BRCC vs FTLF

BRCC
BRC Inc.
BEARISH
Price
$0.95
Market Cap
$108.9M
Sector
Consumer Defensive
AI Confidence
68%
FTLF
FitLife Brands, Inc.
BEARISH
Price
$9.87
Market Cap
$92.7M
Sector
Consumer Defensive
AI Confidence
85%

Valuation

P/E Ratio
BRCC
--
FTLF
15.67
Forward P/E
BRCC
-31.67
FTLF
5.42
P/B Ratio
BRCC
2.27
FTLF
2.12
P/S Ratio
BRCC
0.28
FTLF
1.14
EV/EBITDA
BRCC
-61.2
FTLF
10.02

Profitability

Gross Margin
BRCC
36.33%
FTLF
39.9%
Operating Margin
BRCC
1.99%
FTLF
12.15%
Profit Margin
BRCC
-2.86%
FTLF
7.77%
ROE
BRCC
-47.48%
FTLF
15.86%
ROA
BRCC
-2.74%
FTLF
9.99%

Growth

Revenue Growth
BRCC
2.6%
FTLF
72.6%
Earnings Growth
BRCC
--
FTLF
-23.8%

Financial Health

Debt/Equity
BRCC
0.85
FTLF
1.04
Current Ratio
BRCC
1.33
FTLF
1.53
Quick Ratio
BRCC
0.49
FTLF
0.48

Dividends

Dividend Yield
BRCC
--
FTLF
--
Payout Ratio
BRCC
0.0%
FTLF
0.0%

AI Verdict

BRCC BEARISH

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score prevents a full distress risk assessment. Despite a low Price/Sales ratio of 0.28 suggesting potential undervaluation, the company is unprofitable with negative earnings, a negative ROE of -47.48%, and deteriorating profitability metrics. While recent quarterly earnings have frequently beaten extremely low expectations—sometimes by over 1000%—this reflects poor baselines rather than sustainable progress, and long-term price performance remains deeply negative with a 5-year return of -93.9%. The stock trades significantly below analyst target prices, but fundamental weaknesses, lack of profitability, and inconsistent cash flow data undermine bullish sentiment.

Strengths
Frequent earnings beats with an average surprise of over 300% in recent quarters, signaling possible operational improvements or aggressive cost management
Low Price/Sales ratio of 0.28 suggests potential undervaluation relative to revenue, especially compared to sector average of 11.6% revenue growth
Gross margin of 36.33% is healthy for the Packaged Foods industry, indicating pricing power or efficient production
Risks
Piotroski F-Score of 4/9 indicates weak financial health, particularly concerning for a company with negative earnings and ROE
No Altman Z-Score available prevents proper bankruptcy risk evaluation, a critical gap for a loss-making firm
Negative profit margin (-2.86%) and ROE (-47.48%) reflect ongoing unprofitability and poor capital efficiency
FTLF BEARISH

FTLF exhibits a precarious financial profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a current price ($9.87) that significantly exceeds both its Graham Number ($8.12) and Intrinsic Value ($4.41). While revenue growth is explosive at 72.6%, this has failed to translate into bottom-line success, as evidenced by a -23.8% YoY earnings decline and a consistent track record of missing analyst estimates. The stock is in a severe technical downtrend, losing over 51% of its value in the last six months, suggesting a market repricing of its growth prospects.

Strengths
Exceptional YoY revenue growth of 72.60%
Strong gross margins at 39.90%
Positive ROE of 15.86% relative to sector average
Risks
Severe technical breakdown with 0/100 trend score
Poor earnings quality with an average surprise of -25.74% over last 4 quarters
Liquidity risk indicated by a low Quick Ratio of 0.48

Compare Another Pair

BRCC vs FTLF: Head-to-Head Comparison

This page compares BRC Inc. (BRCC) and FitLife Brands, Inc. (FTLF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile